Andreas Lindstrot
Overview
Explore the profile of Andreas Lindstrot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adler D, Lindstrot A, Ochsenfahrt J, Fuchs K, Wernert N
Int J Mol Med
. 2012 Nov;
31(1):21-5.
PMID: 23135352
Epigenetic changes have been suggested to drive prostate cancer (PCa) development and progression. Therefore, in this study, we aimed to identify novel epigenetics-related genes in PCa tissues, and to examine...
2.
Adler D, Lindstrot A, Buettner R, Wernert N
Oncol Lett
. 2012 Jun;
3(3):513-516.
PMID: 22740941
Prostate cancer (PCa) is one of the most prevalent forms of cancer affecting males worldwide, and knowledge of the immune defenses involved in PCa remains incomplete. Since the identification of...
3.
Adler D, Lindstrot A, Ellinger J, Rogenhofer S, Buettner R, Perner S, et al.
Mol Med Rep
. 2011 Nov;
5(2):313-6.
PMID: 22038307
Predisposition to develop prostate cancer (PCA) varies among the prostate zones, with the peripheral zone (PZ) more prone to tumor development than the transitional zone (TZ). In view of the...
4.
Adler D, Lindstrot A, Ellinger J, Rogenhofer S, Buettner R, Wernert N
Mol Med Rep
. 2011 Oct;
5(1):32-6.
PMID: 21993862
Prostate cancer (PCa) is a clinically heterogeneous and multifocal disease with a clinical outcome that is difficult to predict. Notably, predisposition to develop prostate cancer is different among the prostate...
5.
Adler D, Lindstrot A, Ellinger J, Rogenhofer S, Buettner R, Wernert N
Int J Mol Med
. 2011 Aug;
28(5):799-807.
PMID: 21833467
The role of the immune response in tumor progression, and disease outcome is still debated, and a lack of knowledge of the immune defenses in prostate cancer still exists. In...
6.
Adler D, Lindstrot A, Buettner R, Wernert N
Int J Mol Med
. 2011 Jul;
28(4):605-11.
PMID: 21743959
Prostate cancer (PCA) is a clinically heterogeneous and often multifocal disease with a clinical outcome difficult to predict. A deeper knowledge of the molecular basis of the disease may lead...
7.
Adler D, Lindstrot A, Langer B, Buettner R, Wernert N
Int J Mol Med
. 2011 Apr;
28(1):89-93.
PMID: 21491078
The ETS family of transcription factors plays important roles in both normal and neoplastic cells for different biological processes such as proliferation, differentiation, development, transformation, apoptosis, migration, invasion and angiogenesis....
8.
Adler D, Lindstrot A, Langer B, Buettner R, Wernert N
Int J Mol Med
. 2011 Mar;
27(6):811-9.
PMID: 21424114
Ets-1 is the prototype of the ETS family of transcription factors and is suggested to play an important role in the malignant progression of prostatic carcinomas. Therefore, in this study...
9.
Adler D, Langer B, Lindstrot A, Florin A, Bosserhoff A, Buettner R, et al.
Oncol Rep
. 2011 Jan;
25(4):1125-9.
PMID: 21258770
Different members of the Ets-family of transcription factors are involved in TMPRSS-2-Ets translocations frequently found in human prostate cancers. We previously reported that Ets-1, which is the prototype of Ets-family...